Health
Aprotinin inhibits SARS-CoV-2 entry and replication in cells cultures – News-Medical.Net
Researchers at the University of Kent in the UK and the Hannover Medical School and Goethe University in Germany have observed that the protease inhibitor aprotinin…
Finding a potential therapeutic target to battle the coronavirus disease 2019 (COVID-19) pandemic is crucial. Caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus has now spread to 191 countries worldwide and has infected over 59.17 million people.
Researchers at the University of Kent in the UK and the Hannover Medical School and Goethe University in Germany have observed that the protease inhibitor aprotinin can inhibit viral replication by preventing SARS-CoV-2…
Continue Reading
